Drug-induced Liver Injury With Ritonavir-Boosted Nirmatrelvir: Evidence From Coronavirus Disease 2019 Emergency Use Authorization Adverse Event Reporting System

Detalles Bibliográficos
Autores principales: Li, Guo-Fu, Yu, Guo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the AGA Institute. 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937721/
https://www.ncbi.nlm.nih.gov/pubmed/36801390
http://dx.doi.org/10.1053/j.gastro.2023.02.008
_version_ 1784890485885632512
author Li, Guo-Fu
Yu, Guo
author_facet Li, Guo-Fu
Yu, Guo
author_sort Li, Guo-Fu
collection PubMed
description
format Online
Article
Text
id pubmed-9937721
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher by the AGA Institute.
record_format MEDLINE/PubMed
spelling pubmed-99377212023-02-21 Drug-induced Liver Injury With Ritonavir-Boosted Nirmatrelvir: Evidence From Coronavirus Disease 2019 Emergency Use Authorization Adverse Event Reporting System Li, Guo-Fu Yu, Guo Gastroenterology Correspondence by the AGA Institute. 2023-07 2023-02-18 /pmc/articles/PMC9937721/ /pubmed/36801390 http://dx.doi.org/10.1053/j.gastro.2023.02.008 Text en © 2023 by the AGA Institute. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Correspondence
Li, Guo-Fu
Yu, Guo
Drug-induced Liver Injury With Ritonavir-Boosted Nirmatrelvir: Evidence From Coronavirus Disease 2019 Emergency Use Authorization Adverse Event Reporting System
title Drug-induced Liver Injury With Ritonavir-Boosted Nirmatrelvir: Evidence From Coronavirus Disease 2019 Emergency Use Authorization Adverse Event Reporting System
title_full Drug-induced Liver Injury With Ritonavir-Boosted Nirmatrelvir: Evidence From Coronavirus Disease 2019 Emergency Use Authorization Adverse Event Reporting System
title_fullStr Drug-induced Liver Injury With Ritonavir-Boosted Nirmatrelvir: Evidence From Coronavirus Disease 2019 Emergency Use Authorization Adverse Event Reporting System
title_full_unstemmed Drug-induced Liver Injury With Ritonavir-Boosted Nirmatrelvir: Evidence From Coronavirus Disease 2019 Emergency Use Authorization Adverse Event Reporting System
title_short Drug-induced Liver Injury With Ritonavir-Boosted Nirmatrelvir: Evidence From Coronavirus Disease 2019 Emergency Use Authorization Adverse Event Reporting System
title_sort drug-induced liver injury with ritonavir-boosted nirmatrelvir: evidence from coronavirus disease 2019 emergency use authorization adverse event reporting system
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937721/
https://www.ncbi.nlm.nih.gov/pubmed/36801390
http://dx.doi.org/10.1053/j.gastro.2023.02.008
work_keys_str_mv AT liguofu druginducedliverinjurywithritonavirboostednirmatrelvirevidencefromcoronavirusdisease2019emergencyuseauthorizationadverseeventreportingsystem
AT yuguo druginducedliverinjurywithritonavirboostednirmatrelvirevidencefromcoronavirusdisease2019emergencyuseauthorizationadverseeventreportingsystem

Ejemplares similares